Next |
home / stock / apls / apls message board
Subject | By | Source | When |
---|---|---|---|
news out | IPO$ | investorshub | 05/09/2023 2:24:06 AM |
The gaining last trade up | IPO$ | investorshub | 05/07/2023 6:10:22 PM |
Price now last trade up | IPO$ | investorshub | 05/04/2023 2:09:52 PM |
$APLS are we finally gonna see some action | Pedro2004 | investorshub | 05/01/2023 11:51:02 PM |
where is the squeeze? | wantprofits | investorshub | 04/29/2023 7:51:08 AM |
$APLS oh yeah news for the day | conix | investorshub | 04/28/2023 8:41:20 PM |
$APLS When is this gonna take off? | IPO$ | investorshub | 04/27/2023 8:41:43 AM |
The now | IPO$ | investorshub | 04/26/2023 4:16:27 PM |
$APLS Price now | IPO$ | investorshub | 04/26/2023 11:14:40 AM |
$APLS The now | ComptonBrosInc | investorshub | 04/26/2023 2:58:47 AM |
$APLS Price trading last up | conix | investorshub | 04/24/2023 11:22:18 PM |
$APLS MomentumIts now last up | PickleNick | investorshub | 04/24/2023 6:03:23 AM |
Price now | ClayTrader | investorshub | 04/24/2023 5:57:47 AM |
$APLS Have a look at this | IPO$ | investorshub | 04/24/2023 1:21:47 AM |
MomentumIts gaining last trade up | IPO$ | investorshub | 04/23/2023 5:10:47 PM |
Price now | ComptonBrosInc | investorshub | 04/23/2023 11:55:08 AM |
MomentumIts trading | IPO$ | investorshub | 04/23/2023 4:16:12 AM |
$APLS When is this gonna take off? | IPO$ | investorshub | 04/23/2023 12:59:30 AM |
$APLS The gaining last trade up | IPO$ | investorshub | 04/22/2023 9:15:52 PM |
oh yeah news for the day | IPO$ | investorshub | 04/22/2023 6:45:43 PM |
News, Short Squeeze, Breakout and More Instantly...
Apellis Pharmaceuticals Inc. Company Name:
APLS Stock Symbol:
NASDAQ Market:
Apellis received $375 million in funding at close, with ability to access an additional $100 million Majority of initial proceeds used to buy out...
Apellis received $375 million in funding at close, with ability to access an additional $100 million Majority of initial proceeds used to buy out existing SFJ Pharmaceuticals development liability Significantly improves liquidity profile by eliminating $366 million in SFJ payments...
Generated $172.3 million in 1Q 2024 revenues, including $163.1 million in U.S. net product sales $137.5 million for SYFOVRE® (pegcetacoplan injection) $25.6 million for EMPAVELI® (pegcetacoplan) Anticipates CHMP opinion for pegcetacoplan in GA no later than J...